Vascugen, Inc. announced it raised $10 Million in an initial filing from an offering of $10 Million

Aug 24, 2020•about 5 years ago

Amount Raised

$10 Million

MadisonBiotechnology

Company Information

Company

Vascugen, Inc.

Location

5602 RESEARCH PARK BLVD.

Madison, New Jersey, United States

About

Vascugen is a biotechnology company that is advancing a pipeline of regenerative medicines for treatment of intractable vascular diseases. Our primary target indication is Critical Limb Ischemia (CLI), where new approaches are needed for millions of patients with this highly morbid condition.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Vascugen, Inc. announced it raised $10 Million in an initial filing from an offering of $10 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information